›› 2012, Vol. 7 ›› Issue (10): 781-785.

• 论著 • 上一篇    下一篇

尼莫地平改善脑血管病患者认知功能的有效性观察

贺建华,易进,张娜,李丛佳,范东宁   

  1. 100029 北京首都医科大学附属北京安贞医院精神心理科
  • 收稿日期:2012-04-20 修回日期:1900-01-01 出版日期:2012-10-20 发布日期:2012-10-20
  • 通讯作者: 贺建华

Efficacy on Cognitive Function of Nimodipine in Patients with Cerebral Vascular Disease

HE Jian-Hua, YI Jin, ZHANG Na, LI Cong-Jia, FAN Dong-Ning   

  1. Department of Psychology,Beijing Anzhen Hospital, Capital Medical University, Beijing 100029, China
  • Received:2012-04-20 Revised:1900-01-01 Online:2012-10-20 Published:2012-10-20
  • Contact: HE Jian-Hua

摘要: 目的 该研究旨在观察尼莫地平片对血管性认知损害的短期疗效。方法 前瞻性开放性自身对照研究。64例神经内科门诊脑血管病患者,在常规二级预防药物的基础上,口服尼莫地平60~90 mg/d,12~24周。应用简明精神状态量表(mini mental state examination,MMSE)和北京版蒙特利尔认知评估量表(Montreal cognitive assessment,MoCA)作为认知评估工具,观察治疗前后患者认知功能的变化。结果 三个月治疗后认知成绩总分显著高于治疗前,分别为:MMSE(26.3±2.7)vs(25.6±2.9),P =0.039;MoCA(20.5±4.6)vs(19.0±4.1),P =0.000,差异有显著性;治疗后MoCA的记忆分测验成绩显著高于治疗前,分别为(1.8±1.7)vs(1.1±1.2),P =0.000,差异有显著性。结论 尼莫地平可有效地提高脑血管病患者的认知功能

关键词: 脑血管病; 认知功能; 尼莫地平

Abstract: Objective To observe the efficacy of Nimodipine on vascular cognitive impairment in a shortperiod treatment.Methods It was a prospective opened own control study. Sixty-four patients with cerebrovascular disease were recruited from outpatient of neurology department. On the basis of secondary prevention drugs, patients were given to oral Nimodipine 60-90 mg/d. The patients' cognitive functions have been assessed using the mini mental state examination(MMSE) and Montrealcognitive assessment(MoCA) before and after 12-24 weeks treatment.Results After treatment of Nimodipine, the performance record were significantly better than before, total scores of MMSE were 26.3±2.7 vs 25.6±2.9(P =0.039), MoCA were 20.5±4.6 vs 19.0±4.1(P =0.000), and the memory test of MoCA were significant better than before(1.8±1.7 vs 1.1±1.2, P =0.000).Conclusion Nimodipine may have some benefits for cognitive function in patients with cerebralvascular disease

Key words: Cerebral vascular disease; Cognitive; Nimodipine